|Articles|March 15, 2018

Measles Rears Its Ugly Head Once Again at Newark International Airport

Author(s)Kristi Rosa

The New Jersey Department of Health has issued a public health alert warning of another potential measles exposure at Newark International Airport.

The New Jersey Department of Health (NJ DOH) has issued yet another public health alert warning of potential measles exposure at Newark International Airport.

The highly contagious disease was confirmed in an international traveler who arrived in Terminal B from Brussels and then departed for Memphis, Tennessee from Terminal C on March 12, 2018.

The NJ DOH warns that the traveler, a young child, may have traveled to other areas of the airport, and, as such, anyone who was traveling at the airport between 12:45 PM and 9:00 PM on March 12 may have potentially been exposed to the disease.

“Since measles is still common in many countries, travelers with continue to bring this disease into the United States,” Christina Tan, MD, MPH, state epidemiologist and assistant commissioner of the division of Epidemiology, Environmental and Occupational Health at the NJ DOH told Contagion ®.

One of the most contagious of all infectious diseases, according to the Centers for Disease Control and Prevention (CDC), about 9 in 10 susceptible individuals with close contact to an infected individual will develop the disease.

The best form of protection is to receive the measles, mumps, and rubella (MMR) vaccine.

“Almost everyone who has not had the MMR shot will get measles if they are exposed to the measles virus,” Dr. Tan warned. “The measles vaccine is very effective. One dose of measles vaccine is about 93% effective at preventing measles if exposed to the virus. Two doses are about 97% effective.”

However, despite this high efficacy rate, individuals are still not receiving their recommended vaccinations. Sometimes this is due to vaccine hesitancy, a fear of the risk side effects of vaccination and the safety of vaccine components. Furthermore, some anti-vaxxers are still clinging to a paper that was published in 1998 which linked the MMR vaccine to autism (a paper which has been debunked and withdrawn).

Regardless of the reason, lack of vaccination is equitable to a lack of protection against the disease, which results in more infections, and even outbreaks, as is being seen right now in Europe. Due to declining vaccination rates, the continent has seen a 4-fold increase in measles infections.

Therefore, Dr. Tan and other health officials are stressing the need for individuals to ensure that they are up-to-date on MMR vaccine vaccinations, especially if they plan on traveling internationally.

If an individual presents with febrile rash illness and clinically compatible measles symptoms—cough, coryza, conjunctivitis—health care providers should consider a measles diagnosis and report suspected measles cases to their local health care providers within 24 hours.

Anyone who came in contact with the traveler from Brussels could develop symptoms as late as April 2 if they are infected, the public health alert reads.

New Jersey residents who were flying with the infected individual, and thus, run the risk of exposure, will be notified by their local health department, according to the NJ DOH.


Related to this article

Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
FAQ: Ebola Prevention, Treatment and the Chances of a US Outbreak
As the Bundibugyo virus outbreak in the Democratic Republic of the Congo surpasses 9300 confirmed cases and 4400 deaths, this FAQ explains how the virus spreads, how it presents, why it is hard to diagnose and treat, which vaccines and therapies are being tested, and why CDC considers the risk to the United States low.
Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.